Company / Capital Expenditures
Harvard Apparatus Regenerative Technology, Inc. Capital Expenditures History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
-
FY2024
5-year range
$0 / $11.0K
FY2020-FY2024
Trend
-100.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Remained stable around $0 over the past 3 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, capital expenditures decreased 100.0% year-over-year.
- Peak capital expenditures was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -41.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0 | -100.0% |
| FY2023 | $11.0K | - |
| FY2021 | $0 | -100.0% |
| FY2020 | $7.0K | -94.6% |
| FY2019 | $129.0K | -1.5% |
| FY2018 | $131.0K | -3.7% |
| FY2017 | $136.0K | -55.0% |
| FY2016 | $302.0K | +71.6% |
| FY2015 | $176.0K | -84.9% |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026